Agomelatine in depressed patients with cardiovascular comorbidities: subgroup-analysis of the VIVALDI-studies

被引：0
|
作者：
Laux, G. [1 ]
Barthel, B. [2 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Inst Psychol Med IPM, Dept Psychiat & Psychotherapy, Munich, Soyen, Germany
[2] Servier Deutschland GmbH, Med Affairs, Munich, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2017年 / 27卷
关键词：
ADIPOSE-TISSUE; DISORDER;
D O I：
10.1016/S0924-977X(17)31448-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.b.024
引用
收藏
页码：S798 / S798
页数：1
相关论文
共 50 条
  • [1] Agomelatine in depressed patients with comorbid anxiety: Subgroup-analysis of the VIVALDI-studies
    Laux, G.
    Barthel, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S376 - S376
  • [2] The antidepressant effectiveness of agomelatine in severely depressed and depressed elderly patients : Subgroups of the non-interventional study VIVALDI
    Laux, G.
    Steinmann, C.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 149 - 149
  • [3] Subgroup analysis of the non-interventional study VIVALDI: Agomelatine in treatment-naive patients, in combination therapy and aft er treatment switch
    Laux, Gerd
    Huttner, Nadja A.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2014, 18 (02) : 86 - 96
  • [4] Catumaxomab treatment in gastric-cancer patients with malignant ascites - subgroup-analysis of a pivotal trial
    Heiss, M.
    Linke, R.
    Friccius-Quecke, H.
    Klein, A.
    Hennig, M.
    Lindhofer, H.
    Parsons, S.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 363 - 363
  • [5] Catumaxomab treatment in gastric-cancer patients with malignant ascites: subgroup-analysis of a pivotal trial
    Heiss, M. M.
    Linke, R.
    Klein, A.
    Friccius-Quecke, H.
    Hennig, M.
    Lindhofer, H.
    Parsons, S.
    [J]. ONKOLOGIE, 2010, 33 : 76 - 76
  • [6] Antidepressant effect and tolerabilty of agomelatine in smokers/non-smokers/ex-smokers: results of a subgroup-analysis over 6 months (VITAL-study)
    Lemke, M. R.
    Hajak, G.
    Barthel, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S397 - S398
  • [7] Cardiovascular comorbidities are increased in US patients with haemophilia A: a retrospective database analysis
    Pocoski, J.
    Ma, A.
    Kessler, C. M.
    Boklage, S.
    Humphries, T. J.
    [J]. HAEMOPHILIA, 2014, 20 (04) : 472 - 478
  • [8] CARDIOVASCULAR EFFECTS OF ANTIDEPRESSANTS - STUDIES OF PAROXETINE IN HEALTHY-MEN AND DEPRESSED-PATIENTS
    WARRINGTON, SJ
    LEWIS, Y
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 6 : 59 - 64
  • [9] Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis
    Kravchenko, Julia
    Berry, Mark
    Arbeev, Konstantin
    Lyerly, H. Kim
    Yashin, Anatoly
    Akushevich, Igor
    [J]. LUNG CANCER, 2015, 88 (01) : 85 - 93
  • [10] ANALYSIS OF THE PREVALENCE OF COMORBIDITIES THAT INCREASE CARDIOVASCULAR RISK IN PATIENTS WITH LARGE VESSEL VASCULITIS
    Ferreira, C.
    Pereira, E.
    Althoff, B.
    Fontana, T.
    Castro, G.
    Pereira, I.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S155 - S155
12345